Here are four things to know about the company’s 2023 fourth-quarter and full-year results:
1. Fourth-quarter revenue was $1.46 billion in 2023, a 6.8% increase from 2022.
2. Full-year revenue also increased in 2023, reaching $5.55 billion after recording $5.22 billion in 2022.
3. The company’s operating profit dropped slightly, reporting $425 million in 2023 after hitting $450 million in 2022.
4. Smith+Nephew saw a 5.7% increase in orthopedic growth and a 10% growth in sports medicine and ENT.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
